Using real-time tissue elastography for breast lesion evaluation: our initial experience.

The research team conducted a prospective analysis of consecutive female patients presenting with sonographically visible breast lumps. Review approach involved performing standard B-mode imaging followed by a manual free-hand compression procedure. Investigators assigned elasticity scores to each target based on a established five-point scale. This scale ranges from normal tissue strain to high-rigidity abnormal findings. The design required comparing lesion dimensions across both imaging modalities. Researchers correlated these mechanical measurements with established American College of Radiology reporting standards. Pathologic analysis provided the final confirmation for all included cases. The study protocol adhered to institutional review board requirements and patient consent guidelines.

Key findings from the literature indicate that 61 of 188 lesions were confirmed as malignant through pathology. The data show that 84% of these cancers received high elasticity scores of 4 or 5. Conversely, 76% of the 127 benign lesions were classified with scores of 1 or 2. The technique achieved a sensitivity of 92.7% and a specificity of 85.8% across the study population. There were 4 false-negative and 16 false-positive results recorded during the evaluation period. Among biopsy-proven benign lesions initially categorized as BI-RADS 4A, 82.9% demonstrated low elasticity scores. These results suggest that the method effectively characterizes tissue stiffness in suspicious masses. The findings highlight the potential for improved diagnostic accuracy in clinical breast imaging.

The authors suggest that this imaging modality offers valuable supplementary data for characterizing breast masses. Synthesis and implications indicate that elasticity scoring enhances diagnostic precision beyond standard ultrasound alone. The findings demonstrate that most malignant masses exhibit high strain scores, while benign lumps typically show lower values. Researchers propose that this tool holds potential for refining the management of low-suspicion findings. The data support the integration of stiffness measurements into routine diagnostic workflows. These results highlight a path toward reducing unnecessary biopsies for benign conditions. The study confirms that this approach provides a reliable metric for assessing lesion malignancy. Future clinical practice may benefit from incorporating these mechanical insights into standard reporting protocols.